<?xml version="1.0"?>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:title>Maternal HIV-1 DNA load and mother-to-child transmission</dc:title>
  <dc:creator>Arvold, N. D.</dc:creator>
  <dc:creator>/Ngo Giang Huong, Nicole</dc:creator>
  <dc:creator>McIntosh, K.</dc:creator>
  <dc:creator>Suraseranivong, V.</dc:creator>
  <dc:creator>Warachit, B.</dc:creator>
  <dc:creator>Piyaworawong, S.</dc:creator>
  <dc:creator>Changchit, T.</dc:creator>
  <dc:creator>/Lallemant, Marc</dc:creator>
  <dc:creator>/Jourdain, Gonzague</dc:creator>
  <dc:description>While many factors contribute to mother-to-child transmission (MTCT) of HIV-1, maternal plasma HIV-1 RNA viral load (RNA-VL) has been consistently found as the main risk factor, including when antiretroviral prophylaxis was used to prevent MTCT. However the predictive value of RNA-VL is poor. A recent study of HIV-1-positive pregnant women who did not receive antiretroviral prophylaxis reported an association between HIV-1 DNA viral load (DNA-VL) and MTCT that was stronger than the association between RNA-VL and MTCT. We sought to determine if HIV-1 DNA-VL was independently associated with MTCT of HIV in a population of women who received zidovudine prophylaxis during pregnancy and whose infants received zidovudine after birth. Patients were 33 non-breastfeeding transmitting (TR) and 33 nontransmitting mothers (NTR) from Perinatal HIV Prevention Trial (PHPT-1), a multicenter clinical trial conducted in Thailand comparing zidovudine prophylaxis durations to prevent MTCT. TR and NTR mothers were matched according to baseline RNA-VL. Maternal peripheral blood mononuclear cell (PBMC)-associated HIV-1 DNA was extracted from whole blood, and DNA-VL was established by quantitative real-time polymerase chain reaction. We found that TR had a significantly higher cell-associated HIV-1 DNA viral load than did NTR. Median TR DNA-VL was 2.54 log(10) copies per microgram PBMC DNA, while it was 2.28 log(10) copies per microgram PBMC DNA in NTR (Wilcoxon p = 0.02). In summary, HIV-1 DNA viral load was associated with MTCT in a population of women who received antiretroviral prophylaxis during pregnancy, independently from RNA viral load.</dc:description>
  <dc:date>2007</dc:date>
  <dc:type>text</dc:type>
  <dc:identifier>https://www.documentation.ird.fr/hor/fdi:010052476</dc:identifier>
  <dc:identifier>fdi:010052476</dc:identifier>
  <dc:identifier>Arvold N. D., Ngo Giang Huong Nicole, McIntosh K., Suraseranivong V., Warachit B., Piyaworawong S., Changchit T., Lallemant Marc, Jourdain Gonzague. Maternal HIV-1 DNA load and mother-to-child transmission. 2007, 21 (9),  638-643</dc:identifier>
  <dc:language>EN</dc:language>
</oai_dc:dc>
